|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> 依考匹泮>> 市场分析报告 |
依考匹泮市场分析报告 |
|
Global Market Report of ECOPIPAM (CAS 112107-92-3) December 2024 2020 Tourette Syndrome Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs ... -dihydrotetrabenazine, sepranolone (UC1010), CPP-115, ecopipam (PSYRX 101), ABX-1431, valbenazine ... Dopamine D1 receptor antagonists - Pipeline Insight, 2022 ... approved for clinical use. Ecopipam is a selective D1-like receptor antagonist ... Emerging Drugs Ecopipam (EBS-101): Emalex Biosciences Ecopipam is an investigational first ... fluency disorder (Stuttering) in adults. Ecopipam selectively blocks the actions of ... Gilles de la Tourette’s syndrome ... Tourette’s syndrome Emerging Drugs Ecopipam: Emalex Biosciences Ecopipam is an investigational first-in-class drug ... fluency disorder (Stuttering) in adults. Ecopipam selectively blocks the actions of the ... SOM Biotech Key Products Ecopipam THX-110 CPP 115 ... Tourette Syndrome (Central Nervous System) - Drugs in Development, 2021 Tourette Syndrome (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tourette Syndrome - Drugs in Development, 2021, provides an overview of the Tourette ... Global Tourette Syndrome Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 ... AZD-5213 CPP-115 Dutetrabenazine ER Ecopipam Hydrochloride Others Market segment by Application ... Global Tourette Syndrome Drug Market Growth 2025-2031 ... : AZD-5213 CPP-115 Dutetrabenazine ER Ecopipam Hydrochloride Others Segmentation by Application: Research ... Tourette Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Tourette Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tourette Syndrome Drugs in Development by Stages, ... Tourette Syndrome Drug Market - Global Outlook and Forecast 2022-2028 ... (%) AZD-5213 CPP-115 Dutetrabenazine ER Ecopipam Hydrochloride Others Global Tourette Syndrome ... Global Plasma Expander Market Growth 2025-2031 The global Plasma Expander market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from ... Dopamine receptor antagonists - Pipeline Insight, 2022 ... Vanda Pharmaceuticals Neurogastrx Key Products Ecopipam INP 105 ITI-333 Iloperidone ... 2023-2028 Global and Regional Tourette Syndrome Drug Industry Status and Prospects Professional Market Research Report Standard Version ... : AZD-5213 CPP-115 Dutetrabenazine ER Ecopipam Hydrochloride Others By Applications: Research Center ... Global Tourette Syndrome Drug Market Research Report 2025(Status and Outlook) ... ) AZD-5213 CPP-115 Dutetrabenazine ER Ecopipam Hydrochloride Others Market Segmentation (by Application ... Tourette Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major Tourette syndrome markets reached a value of US$ 1,818.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2,710.2 Million by 2034, exhibiting a growth rate (CAGR) of 3.7% during 2024-2034. The Tourette syndrome market ... Global Developmental Stuttering Therapeutics Market Research Report 2025(Status and Outlook) ... companies like Emalex Biosciences (developing ecopipam) and other biotech firms exploring ... |